143 related articles for article (PubMed ID: 36146795)
1. SARS-CoV-2 Production, Purification Methods and UV Inactivation for Proteomics and Structural Studies.
Plavec Z; Domanska A; Liu X; Laine P; Paulin L; Varjosalo M; Auvinen P; Wolf SG; Anastasina M; Butcher SJ
Viruses; 2022 Sep; 14(9):. PubMed ID: 36146795
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of stability and inactivation methods of SARS-CoV-2 in context of laboratory settings.
Widera M; Westhaus S; Rabenau HF; Hoehl S; Bojkova D; Cinatl J; Ciesek S
Med Microbiol Immunol; 2021 Aug; 210(4):235-244. PubMed ID: 34196781
[TBL] [Abstract][Full Text] [Related]
3. Assessment of inactivation procedures for SARS-CoV-2.
Auerswald H; Yann S; Dul S; In S; Dussart P; Martin NJ; Karlsson EA; Garcia-Rivera JA
J Gen Virol; 2021 Mar; 102(3):. PubMed ID: 33416462
[TBL] [Abstract][Full Text] [Related]
4. Effect of Inactivation Methods on SARS-CoV-2 Virion Protein and Structure.
Loveday EK; Hain KS; Kochetkova I; Hedges JF; Robison A; Snyder DT; Brumfield SK; Young MJ; Jutila MA; Chang CB; Taylor MP
Viruses; 2021 Mar; 13(4):. PubMed ID: 33810401
[TBL] [Abstract][Full Text] [Related]
5. Analysis of Inactivation of SARS-CoV-2 by Specimen Transport Media, Nucleic Acid Extraction Reagents, Detergents, and Fixatives.
Welch SR; Davies KA; Buczkowski H; Hettiarachchi N; Green N; Arnold U; Jones M; Hannah MJ; Evans R; Burton C; Burton JE; Guiver M; Cane PA; Woodford N; Bruce CB; Roberts ADG; Killip MJ
J Clin Microbiol; 2020 Oct; 58(11):. PubMed ID: 32839250
[TBL] [Abstract][Full Text] [Related]
6. SARS-CoV-2 inactivation in laboratory animal tissues with 4% formaldehyde or 5% glutaraldehyde for transfer to biosafety level 1 laboratories.
Pilchová V; Elmontaser Mergani A; Clever S; Ciurkiewicz M; Becker K; Gerhauser I; Baumgärtner W; Volz A; von Köckritz-Blickwede M; Schulz C
Vet Pathol; 2024 Mar; 61(2):201-206. PubMed ID: 37698272
[TBL] [Abstract][Full Text] [Related]
7. Inactivation of SARS-CoV-2 and COVID-19 Patient Samples for Contemporary Immunology and Metabolomics Studies.
Eddins DJ; Bassit LC; Chandler JD; Haddad NS; Musall KL; Yang J; Kosters A; Dobosh BS; Hernández MR; Ramonell RP; Tirouvanziam RM; Lee FE; Zandi K; Schinazi RF; Ghosn EEB
Immunohorizons; 2022 Feb; 6(2):144-155. PubMed ID: 35173021
[TBL] [Abstract][Full Text] [Related]
8. Extracellular Vesicles Analysis in the COVID-19 Era: Insights on Serum Inactivation Protocols towards Downstream Isolation and Analysis.
Frigerio R; Musicò A; Brucale M; Ridolfi A; Galbiati S; Vago R; Bergamaschi G; Ferretti AM; Chiari M; Valle F; Gori A; Cretich M
Cells; 2021 Mar; 10(3):. PubMed ID: 33806297
[TBL] [Abstract][Full Text] [Related]
9. Rapid, dose-dependent and efficient inactivation of surface dried SARS-CoV-2 by 254 nm UV-C irradiation.
Ruetalo N; Businger R; Schindler M
Euro Surveill; 2021 Oct; 26(42):. PubMed ID: 34676820
[TBL] [Abstract][Full Text] [Related]
10. Heat inactivation of clinical COVID-19 samples on an industrial scale for low risk and efficient high-throughput qRT-PCR diagnostic testing.
Delpuech O; Douthwaite JA; Hill T; Niranjan D; Malintan NT; Duvoisin H; Elliott J; Goodfellow I; Hosmillo M; Orton AL; Taylor MA; Brankin C; Pitt H; Ross-Thriepland D; Siek M; Cuthbert A; Richards I; Ferdinand JR; Barker C; Shaw R; Ariani C; Waddell I; Rees S; Green C; Clark R; Upadhyay A; Howes R
Sci Rep; 2022 Feb; 12(1):2883. PubMed ID: 35190592
[TBL] [Abstract][Full Text] [Related]
11. Methods of SARS-CoV-2 Inactivation.
Anderson ER; Prince T; Turtle L; Hughes GL; Patterson EI
Methods Mol Biol; 2022; 2452():465-473. PubMed ID: 35554921
[TBL] [Abstract][Full Text] [Related]
12. Rapid and complete inactivation of SARS-CoV-2 by ultraviolet-C irradiation.
Storm N; McKay LGA; Downs SN; Johnson RI; Birru D; de Samber M; Willaert W; Cennini G; Griffiths A
Sci Rep; 2020 Dec; 10(1):22421. PubMed ID: 33380727
[TBL] [Abstract][Full Text] [Related]
13. Methods of Inactivation of SARS-CoV-2 for Downstream Biological Assays.
Patterson EI; Prince T; Anderson ER; Casas-Sanchez A; Smith SL; Cansado-Utrilla C; Solomon T; Griffiths MJ; Acosta-Serrano Á; Turtle L; Hughes GL
J Infect Dis; 2020 Oct; 222(9):1462-1467. PubMed ID: 32798217
[TBL] [Abstract][Full Text] [Related]
14. Propagation, Inactivation, and Safety Testing of SARS-CoV-2.
Jureka AS; Silvas JA; Basler CF
Viruses; 2020 Jun; 12(6):. PubMed ID: 32517266
[TBL] [Abstract][Full Text] [Related]
15. Inactivation of SARS-CoV-2 Laboratory Specimens.
Haddock E; Feldmann F; Shupert WL; Feldmann H
Am J Trop Med Hyg; 2021 Apr; 104(6):2195-2198. PubMed ID: 33878029
[TBL] [Abstract][Full Text] [Related]
16. Selection and application of biological safety cabinets in diagnostic and research laboratories with special emphasis on COVID-19.
Pawar SD; Khare AB; Keng SS; Kode SS; Tare DS; Singh DK; More RL; Mullick J
Rev Sci Instrum; 2021 Aug; 92(8):081401. PubMed ID: 34470433
[TBL] [Abstract][Full Text] [Related]
17. A validated protocol to UV-inactivate SARS-CoV-2 and herpesvirus-infected cells.
Soh TK; Pfefferle S; Wurr S; von Possel R; Oestereich L; Rieger T; Uetrecht C; Rosenthal M; Bosse JB
PLoS One; 2023; 18(5):e0274065. PubMed ID: 37163509
[TBL] [Abstract][Full Text] [Related]
18. Regeneration of Capto Core 700 resin through high throughput and laboratory scale studies and impact on production of a SARS-CoV-2 vaccine candidate.
Konstantinidis S; Reinhart SR; Castagna C; Poplyk MR; Rustandi RR; Flor KL; Acevedo-Skrip J; Thompson R; Wang CJ; Wang SC; Winters MA
Biotechnol J; 2022 Oct; 17(10):e2200191. PubMed ID: 35771570
[TBL] [Abstract][Full Text] [Related]
19. Development of a Single-Cycle Infectious SARS-CoV-2 Virus Replicon Particle System for Use in Biosafety Level 2 Laboratories.
Malicoat J; Manivasagam S; Zuñiga S; Sola I; McCabe D; Rong L; Perlman S; Enjuanes L; Manicassamy B
J Virol; 2022 Feb; 96(3):e0183721. PubMed ID: 34851142
[TBL] [Abstract][Full Text] [Related]
20. Potential False-Negative Nucleic Acid Testing Results for Severe Acute Respiratory Syndrome Coronavirus 2 from Thermal Inactivation of Samples with Low Viral Loads.
Pan Y; Long L; Zhang D; Yuan T; Cui S; Yang P; Wang Q; Ren S
Clin Chem; 2020 Jun; 66(6):794-801. PubMed ID: 32246822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
